Chargement en cours...
Allogeneic hematopoietic cell transplantation for MDS: For whom, when and how?
Hematopoietic cell transplantation (HCT) is currently the only treatment with curative potential for patients with myelodysplastic syndrome (MDS). However, treatment-related mortality and relapse have remained major barriers to uniform success. Therefore, important questions remain to be answered, s...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3509173/ https://ncbi.nlm.nih.gov/pubmed/22981712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.blre.2012.08.002 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|